Project Grant HT94252510804
Award Date
9/30/25
Completion Date
9/29/27
Dollars Obligated
$156K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
This Project Grant award of $894,125.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to understand and target epigenetic vulnerabilities in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors (NF1-MPNST) at Washington University. The research aims to transform healthcare for military service members, veterans, and the public by investigating innovative medical solutions. The 3-year...
The federal Project Grant award, valued at $250,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Washington University's Office of Sponsored Research Services Division. The award will fund a study on the "SUBCLINICAL PATHOPHYSIOLOGY OF MOTOR PROCESSING IN PEOPLE WITH MULTIPLE SCLEROSIS" over a 2-year period from September 30, 2024 to September 29, 2026. As a prominent private research university, The...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $311,000.00 in funding to The Washington University in University City, Missouri. The award supports a 2-year research project using biomedical informatics and artificial intelligence to improve detection of degenerative cervical myelopathy, a neurological disorder. As a prominent private research university, The Washington University has extensive...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The federal Project Grant award of $500,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Washington University to accelerate the diagnosis of inflammatory arthritis. The project aims to harness single-cell T cell-receptor sequencing to develop innovative diagnostic approaches. The research is being conducted at Washington University's Office of Sponsored Research Services Division over a 2-year performance period from...
The federal Project Grant award of $210,292 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to develop "Deuterium Metabolic Imaging to Noninvasively Measure Metabolic Reprogramming in Glioblastoma", a project focused on advancing imaging techniques to better understand metabolic changes in brain cancer. The award was granted to The Washington University, a private research institution,...
This federal Project Grant award of $256,208 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a research project titled "DEUTERIUM METABOLIC IMAGING TO NONINVASIVELY MEASURE METABOLIC REPROGRAMMING IN GLIOBLASTOMA" at The Washington University in University City, Missouri. The project aims to develop and apply advanced metabolic imaging techniques using deuterium to non-invasively measure metabolic changes in glioblastoma, an...
This $437,544 Project Grant award was made on September 30, 2023 by the Defense Health Agency under the CFDA 12.420 Military Medical Research and Development program. The grant supports research at The Washington University in St. Louis, Missouri to study the phosphorylation tau profile of veterans with traumatic brain injury (TBI). The 3-year research project aims to improve understanding of neurological conditions affecting military service members and veterans. As a prominent private research...
The Department of Defense's Defense Health Agency awarded a $1,127,375 Project Grant to The Washington University Office of Sponsored Research Services Division under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from Sep 30, 2023 to Sep 29, 2027, will fund research on "REPLICATION DRIVEN VULNERABILITIES IN CYCLIN E OVEREXPRESSING OVARIAN CANCERS". As a prominent research institution with expertise in biomedical sciences, The Washington...
The Department of Defense's Defense Health Agency awarded a $155,500 Project Grant to The Washington University's Office of Sponsored Research Services Division to support a research project titled "ACTIVATION OF AN IMMUNE EVASION-TO-IMMUNE RECOGNITION SWITCH THROUGH THE INDUCTION OF IRF3 SIGNALING IN CRPCS". The grant, funded through the Military Medical Research and Development program (CFDA 12.420), will be executed over a 2-year period from May 1, 2024 to April 30, 2026. The...